Professional Documents
Culture Documents
Post-Tonsillectomy Analgesia:
A Randomized Trial
Lauren E. Kelly, PhDa,b, Doron D. Sommer, MDc, Jayant Ramakrishna, MDc, Stephanie Hoffbauer, BHScc,
Sadaf Arbab-tafti, BHScc, Diane Reid, MDc, Jonathan Maclean, MDc, Gideon Koren, MDa,b,d
BACKGROUND: Pediatric sleep disordered breathing is often caused by hypertrophy of the tonsils abstract
and is commonly managed by tonsillectomy. There is controversy regarding which
postsurgical analgesic agents are safe and efficacious.
METHODS: Thisprospective randomized clinical trial recruited children who had sleep disordered
breathing who were scheduled for tonsillectomy +/2 adenoid removal. Parents were provided
with a pulse oximeter to measure oxygen saturation and apnea events the night before and the
night after surgery. Children were randomized to receive acetaminophen with either 0.2–0.5
mg/kg oral morphine or 10 mg/kg of oral ibuprofen. The Objective Pain Scale and Faces Scale
were used to assess effectiveness on postoperative day 1 and day 5. The primary endpoint was
changes in respiratory parameters during sleep.
RESULTS: A total of 91 children aged 1 to 10 years were randomized. On the first postoperative
night, with respect to oxygen desaturations, 86% of children did not show improvement in the
morphine group, whereas 68% of ibuprofen patients did show improvement (14% vs 68%;
P , .01). The number of desaturation events increased substantially in the morphine group,
with an average increase of 11.17 6 15.02 desaturation events per hour (P , .01). There were
no differences seen in analgesic effectiveness, tonsillar bleeding, or adverse drug reactions.
CONCLUSIONS:Ibuprofen in combination with acetaminophen provides safe and effective
analgesia in children undergoing tonsillectomy. Post-tonsillectomy morphine use should be
limited, as it may be unsafe in certain children.
a
Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, and bIvey Chair in WHAT’S KNOWN ON THIS SUBJECT: Sleep apnea
Molecular Toxicology, Western University, London, Ontario, Canada; cHead & Neck Surgery Division, Department of
is a common condition in childhood, mainly
Surgery-Otolaryngology, McMaster University Medical Centre, Hamilton, Ontario, Canada; and dDivision of Clinical
Pharmacology and Toxicology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, managed by tonsillectomy. Codeine was recently
Toronto, Ontario, Canada contraindicated for pain management after
Dr Kelly wrote the first draft of the manuscript and was responsible for study design, data analysis, surgery. Controversy exists regarding the safety
and interpretation; Drs Sommer and Maclean were responsible for study design and and effectiveness of alternative medications,
implementation (surgeries, data collection, and patient follow-up), as well as writing and revising
morphine, and ibuprofen.
the manuscript; Drs Ramakrishna and Reid were responsible for data collection, surgeries, and
patient follow-up; Ms Hoffbauer and Ms Arbabtafti were responsible for patient recruitment data WHAT THIS STUDY ADDS: Our findings suggest
collection and data entry; and Dr Koren was responsible for study design, obtaining funding, study
oversight, data interpretation, manuscript revisions, and formatting.
that ibuprofen does not increase tonsillar
bleeding and in combination with acetaminophen
This trial has been registered at www.clinicaltrials.gov (identifier NCT01680939).
is effective for pain management after
www.pediatrics.org/cgi/doi/10.1542/peds.2014-1906
tonsillectomy. Furthermore, standard morphine
DOI: 10.1542/peds.2014-1906
doses increased postoperative respiratory
Accepted for publication Nov 5, 2014 events and were not safe in all children.
DISCUSSION
Our study reveals that for children
undergoing tonsillectomy, the
standard dose range of morphine
analgesia increases the risk for oxygen
desaturation in comparison with
ibuprofen. Furthermore, no
FIGURE 1 differences in analgesic effectiveness
Recruitment flow diagram created using the CONSORT guidelines.38 Other reasons for approached
or rates of post-tonsillar hemorrhage
patients not being randomized include language barriers and parents asking specifically for
morphine (not wanting to be randomized). Patients who did not follow randomization did not take were identified between children
the medication they were randomized to receive. All patients who were allocated to either morphine receiving morphine and those
or ibuprofen were included in the intent-to-treat analysis. Only those who had oximeter data receiving ibuprofen. In young children,
available were included in the primary outcome analysis.
tonsillectomy 6 adenoidectomy have
been reported to improve SDB, but
that evening. Three hours after her saturation on arrival was 76% and only in up to 65% of children.13–15
2-AM morphine dose, her parents she was promptly administered Perioperative respiratory
noticed her lips were blue and she 0.05 mg intravenous naloxone and complications necessitating a medical
had a slow heart rate and was supplemental O2. She was admitted intervention may occur in more than
unresponsive, and returned her to the into the PICU and morphine was 10% of children undergoing
emergency department. Her O2 discontinued. While admitted, chest adenotonsillectomy, with more than
60% of these occurring in the
TABLE 2 Patient Demographics in the Morphine and Ibuprofen Groups immediate postoperative period.16–18
Demographics Morphine (N = 46) Ibuprofen (N = 38) Desaturations can continue for an
Age, y 5.07 (2.45) 5.14 (2.25) unpredictable period of time and in
Weight, kg 27.36 (8.78) 22.38 (9.59) a substantial number of children,
BMI 17.31 (3.00) 18.29 (4.56) possibly owing to prolonged changes
Gender, female 50% (23) 54% (22) in the threshold of response to
Preoperative tonsil size 2.80 (0.61) 3.05 (0.58)
hypoxemia. Moreover, children can
Total number of desaturation events (preoperative) 3.55 (3.63) 4.51 (8.48)
Diagnosis experience laryngospasm, airway
SDB 57% (26) 48% (19) swelling, and pulmonary edema,
Obstructive sleep apnea 32% (15) 45% (18) leading to further desaturation and
SDB with recurrent tonsillitis 11% (5) 7% (3) even to respiratory arrest.14 In such
Ethnicity
cases, in which apnea is not improved
Caucasian 87% (40) 93% (38)
African American 7% (3) 7% (3) after surgery, providing opioids to
Middle Eastern 4% (2) 0 relieve pain has the potential to
South American 2% (1) 0 increase respiratory depression,
Data are presented as mean (SD) for continuous variables, and as a percentage for categorical data. through the action of m and k opioid
Address correspondence to Gideon Koren, MD, FRCPC, FACMT, Division of Clinical Pharmacology/Toxicology, Department of Pediatrics, The Hospital for Sick Children
and The University of Toronto, Toronto, M5G 1X8, Canada. E-mail: gkoren@sickkids.ca
PEDIATRICS (ISSN Numbers: Print, 0031-4005; Online, 1098-4275).
Copyright © 2015 by the American Academy of Pediatrics
FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.
FUNDING: Supported by a grant from the Canadian Institutes for Health Research Drug Safety and Effectiveness Network (DSEN).
POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.
REFERENCES
1. Baugh RF, Archer SM, Mitchell RB, et al. obstructive sleep apnea. Anesth Analg. 5. US Food and Drug Administration. Safety
Clinical practice guideline: 2009;109(1):60–75 review update of codeine use in children;
tonsillectomy in children. Otolaryngol 3. Chhangani BS, Melgar T, Patel D. new boxed warning and contraindication
Head Neck Surg. 2011;144(1 suppl): Pediatric obstructive sleep apnea. Indian on use after tonsillectomy and/or
S1–S30 J Pediatr. 2010;77(1):81–85 adenoidectomy. Available at: www.fda.
2. Schwengel DA, Sterni LM, Tunkel DE, 4. Cullen KA, Hall MJ, Golosinskiy A. gov/downloads/Drugs/DrugSafety/
Heitmiller ES. Perioperative Ambulatory surgery in the United States, UCM339116.pdf. Accessed January 25,
management of children with 2006. Natl Health Stat Rep. 2009; (11):1–25 2014
Updated Information & including high resolution figures, can be found at:
Services http://pediatrics.aappublications.org/content/135/2/307
References This article cites 30 articles, 3 of which you can access for free at:
http://pediatrics.aappublications.org/content/135/2/307#BIBL
Subspecialty Collections This article, along with others on similar topics, appears in the
following collection(s):
Ear, Nose & Throat Disorders
http://www.aappublications.org/cgi/collection/ear_nose_-_throat_dis
orders_sub
Pharmacology
http://www.aappublications.org/cgi/collection/pharmacology_sub
Therapeutics
http://www.aappublications.org/cgi/collection/therapeutics_sub
Permissions & Licensing Information about reproducing this article in parts (figures, tables) or
in its entirety can be found online at:
http://www.aappublications.org/site/misc/Permissions.xhtml
Reprints Information about ordering reprints can be found online:
http://www.aappublications.org/site/misc/reprints.xhtml
The online version of this article, along with updated information and services, is
located on the World Wide Web at:
http://pediatrics.aappublications.org/content/135/2/307
Pediatrics is the official journal of the American Academy of Pediatrics. A monthly publication, it
has been published continuously since 1948. Pediatrics is owned, published, and trademarked by
the American Academy of Pediatrics, 141 Northwest Point Boulevard, Elk Grove Village, Illinois,
60007. Copyright © 2015 by the American Academy of Pediatrics. All rights reserved. Print
ISSN: 1073-0397.